Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2%

This study has been completed.

Study NCT00697541 Information provided by Galderma

First Received: June 12, 2008 Last Updated: January 4, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2008
Primary Completion Date:	June 2008 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: October 16, 2010